Latigo Biotherapeutics, Inc.

Nasdaq: LTGOGrowth candidate

64 days public · Pharmaceutical Preparations · $16.00 (+8.18%)

Growth candidate RANKED

/ 100 fit

Confidence100%

Latigo Biotherapeutics, Inc. (LTGO) received a Growth strategy-fit score of 70 out of 100, driven by strong institutional backing and positive short-term market momentum, offset by early-stage fundamental performance.

Intelligence score

/ 100 core

Suggested alloc

30%

cap · your limits

Days public

EARLY PUBLIC

Last price

$16.00

live quote

1d change

+8.18%

session

Why selectedLIVE

EQUENCY Reasoning Engine

+High institutional ownership score of 93, supported by four Schedule 13D/13G filings with the SEC.
+Positive price momentum with a 1-day move of +8.18%, contributing to a Momentum score of 66.
+Active narrative engagement demonstrated by two 8-K filings and twenty insider forms with the SEC, yielding a Narrative score of 78.

RisksLIVE